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ABSTRACT 
Introduction: Peptic ulcer disease is the most predominant gastrointestinal diseases.The 
current treatment strategies have multiple drawbacks due to side effects and complexity of 
administration.An Endeavour to search an ideal anti- ulcer agent from medicinal plant reports 
is going on. In the present study, we investigated the anti -ulcer effect of hydromethanolic 
extract and solvent fractions of F. thonningii stem bark.  
Objectives:To evaluate the anti-ulcer effect of F.thonningii stem bark on ulcer induced 
rodent models. 
Methods:F.thonningii stem bark was collected and the shed dried plant material was 
macerated and extracted by 80% hydromethanol.Part of the dried crude extract was further 
fractionated with different solvents.Hydromethanolic crude extract was used for acute 
toxicity test,phytochemical screening and antiulcer activity test on pylorus ligation and 
indomethacine induced ulcer model. While, the time dependent study on ethanol induced 
ulcer was evaluated by both the crude extract and solvent fractions. Preliminary 
phytochemical screening was done based on standard procedures.Acute toxicity study was 
carried out on Swiss albino mice.  
Results: Preliminary phytochemical screening showed the presence of: Saponins, Flavonoids, 
Terpinoids, Glycosides, Anthraquinones, Tannins, Alkaloids and Phenolic compounds. The 
extract showed significant reduction in Total acidity (CEFT 100,200,400mg/kg) 
(P<0.001);Gastric volume (CEFT 100) (P<0.01);(CEFT 200,400mg/kg) (P<0.001), pH 
(CEFT200,400 mg/kg)(P<0.05) and Ulcer Index (CEFT 200,400mg/kg) (P<0.05) as 
compared to  the negative control. The crude extract and aqueous fractions of F.thonningii 
200 mg/kg showed significant  reduction on ulcer index (P<0.05) on repeated dose 
administered groups of ulcerated animals induced by ethanol. Ulcer healing effect on 
indomethacine induced ulcer were not significant (P˃0.05) for all  three doses (CEFT100, 
200,400 mg/kg). No sign of toxicity was observed up to the limit dose (2000mg/kg). 
Discussion and Conclusion: This study demonstrated F.thonningii stem bark has a potential 
anti-ulcer activity that might be due to anti-secretory or cytoprotective effect of the plant’s 
phytochemicals. 
Key Words: Ethanol, F.thonningii, Pylorus Ligation, Solvent fractions, Ulcer healing. 
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1. INTRODUCTIONON 
1.1 BACKGROUND 
Peptic ulcer disease is an erosion in a part of the gastro intestinal mucosa, typically in the 
stomach (gastric ulcer) or first few centimeters of duodenum (duodenal ulcer) that may pass 
through the muscularis mucosa(1). 
It is the most prevalent gastrointestinal disease with a worldwide prevalence of about 40% in 
developed and 80% in developing countries (2).In United States alone, the annual cost 
associated with peptic ulcer disease is estimated to be $6 billion. It can also leads to gastric 
cancer which kills over 700000 people per year globally. Although most studies reported that 
a decrease in the incidence or prevalence of GI disorders over time due to a decrease in H. 
pylori associated cases, peptic ulcer disease remains a common condition (3) as it was 
reported with point prevalence of 59.6% in Bangladesh  (4) and 33.4%  in Brazil (5).In 
Ethiopia,PUD is highly associated with H. pylori infection, alcohol intake and age (6-8).It is 
the leading among the top Ten diseases of Hospital admission In south Africa 
(9).Complications of peptic ulcer disease have also severe health and economic burden 
globally that leads to prolonged hospital stay for patients and therapeutic management 
complication for health care workers. Such as perforation which becomes a global 
emergency with mortality rates of 30% (10) ,Hemorrhage,obstruction,pyloric stenosis (late 
complication characterized by lots of vomiting), lymphoma and gastric cancer due to Vac A 
and Cag A strain of H. pylori and even risk of osteoporosis for those treated with PPIs (11).In 
Kenya, perforated peptic ulcer was reported mainly on young males (12).In 
Tanzania,Gastritis (61.10%), Gastro esophageal Reflux Disease(57%),Peptic Ulcer Disease 
(24.1%) and Gastric cancer (6.7%) are the leading causes of dyspepsia (13).In Ethiopia, a 
report in Karamara Hospital showed 78 from 92 patients were admitted with gastric outlet 
obstruction secondary to PUD (14).Another report in Tikur anbessa Hospital indicated 
patients with Complicated PUD comprised 3.8% of the total major surgical procedures (15) 
and 6.7% of hospital admission in St.Poul Hospital (16). 
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1.1.1 Etiology of Peptic Ulcer Disease 
Peptic ulcer disease occurs due to an imbalance between mucosal damaging (acid, pepsin) 
and protecting (mucus, bicarbonate, Prostaglandin E2and I2) mechanisms. Acid secretion is a 
physiologically useful process of the stomach as gastric acid induces pepsinogen activation to 
initiate digestive process and kills microbes and ensuring a stable intra-gastric environment. 
Endogenous secretagogues (positive regulators) of acid secretion are Acetylcholine, 
Histamine and Gastrin. While Prostaglandins (PG E2 and I2) act as negative regulators of 
acid secretion. Helicobacter pylori infection is the major  Risk factor (approximately 80%) 
(17) and its Eradication reduces the incidence  and relapse rate of ulcers(7, 18-20). 
NSAIDs,Steroids , Smoking , Alcohol , Stress and Depression are also etiologic agents for 
PUD (21).Sometimes, Acid hypersecretion due to Zollinger-Ellison-gastrine secreting tumor 
(gastrinoma) is also responsible for multiple ulcers. Even, treatment with high dose of PPI or 
curative resection leads to loss of negative feedback on acid secretion, increase histamine 
production and abnormal gastric emptying (too fast can give duodenal ulcers and too slow 
can cause gastric ulcers).Some unavoidable factors are also associated with gastric 
ulcer:Sex,age, ethnic backgrounds (African- Americans or Hispanics have 2-fold 
higher),Chronic diseases such as Congestive Heart Failure, blood group(type O),Genetics 
(Pepsinogen C gene polymorphism), radiation damage and viral infections are the main 
causes for PUD (22). 
1.1.2 Pathophysiology of Peptic Ulcer Disease 
Physiologically, gastric mucosal barrier is composed mainly of protective luminal mucus 
layer, gastric epithelial barrier, immune cells, gastric microcirculation and sensory gastric 
innervations. When gastric mucosa gets exposed to damage by gastric acid or other irritating 
chemical, afferent neurons are activated and directly start controlling the tone of the sub-
mucosal arterioles, which regulate mucosal blood flow. When sensory afferent nerves of the 
superficial mucosa detect gastric acid, they respond by releasing neurotransmitters as 
substance P and calcitonin gene-related peptide. These mediators cause relaxation of smooth 
muscle surrounding gastric mucosal arterioles, resulting in elevation of mucosal blood flow. 
In addition, vagal activation increases mucus secretion, while nervous response to stress 
control central corticotropin-releasing factor signaling pathways. Furthermore, the transient 
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receptor potential vanilloid-1 agonists are effective in protecting gastric mucosa against 
various experimentally induced ulcer models(22). 
The stomach mucosa has two important types of tubular glands: oxyntic and pyloric glands. 
The oxyntic glands secrete hydrochloric acid, pepsinogen, intrinsic factor and mucus. The 
pyloric glands secrete mainly mucus for protection of the pyloric mucosa from the stomach 
acid. They also secrete the hormone gastrin. A typical stomach oxyntic gland is composed of 
three types of cells: (1) Mucus neck cells, which secrete mainly mucus; (2) peptic (chief) 
cells, which secrete large quantities of pepsinogen; and (3) parietal (oxyntic) cells, which 
secrete an isotonic solution of essentially pure hydrochloric and intrinsic factor. The pH of 
this solution is as low as 0.8, the concentration of H+ being a million times higher than that of 
plasma. Carbonic Anhydrase enzyme abundantly present in the gastric parietal cell combines 
carbon dioxide and water forming carbonic acid, from where bicarbonate ion (HCO3
-) is 
exchanged with plasma Cl-. H+ ion is pumped out against the concentration gradient into the 
gastric lumen by H+/K+ATPase that is located in the apical membrane of the parietal cells. 
This pump generates the largest  ion gradient in vertebrates, with an intracellular pH of about 
7.3 and an intra-canalicular pH of about 0.8.Parietal cells contain receptors for Histamine, 
Gastrin, and Acetylcholine (23). Gastrin is secreted by endocrine cells in the gastric antrum 
and duodenum. Pepsinogen, the inactive precursor of pepsin, is secreted by the chief cells 
located in the gastric fundus. Pepsin is activated by optimal acidic pH of 1.8 to 3.5, 
inactivated reversibly at pH 4, and irreversibly destroyed at pH 7 (24). Histamine activates 
histamine-2 receptors on the acid-producing parietal cells to stimulate acid production. In 
addition, any imbalance in the activity of antioxidant enzymes like Superoxide dismutase 
(SOD), Catalase (CAT) and Gluthathione peroxidase (GPX) may lead to faulty disposal of 
free radicals which leads to gastric mucosal damage and ulcer. Disturbance of apoptosis 
balance, bile salts that destroy the permeability barrier of gastric mucosa and increase 
mucosal permeability to acids. Any disturbance in ulcer healing process also leads to peptic 
ulcer disease. Ulcer healing process includes inflammation, cell proliferation, re-
epithelialization, formation of granulated tissue, angiogenesis, interactions between various 
cells and the matrix and tissue remodeling, all these events are controlled by Cytokines, 
Growth factors (EGF),Gastrointestinal hormones (Gastrin,CCK)and Orexigenic peptides 
(ghrelin,orexine-A and obestatine),Transcription factors, as well as COX-2 are important for 
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epithelial cell proliferation and reconstruction of gastric glands during gastric ulcer healing. 
Nitric oxide, Endothelin, Prostaglandins and Metalloproteinase’s are important for vascular 
remodeling and mucosal regeneration within gastric ulcer(25, 26). 
1.1.3 Diagnosis of Peptic Ulcer Disease 
Peptic ulcer disease can be diagnosed by different techniques starting from patients history, 
physical examination for signs and symptoms which consist of a sensation of pain or burning 
in the epigastrium, early satiety (inability to finish a normal-sized meal),fullness during or 
after a meal, or a combination of these symptoms. The true incidence of peptic ulcer depends 
on satisfactory case-history data; and- good diagnostic facilities. Since diagnostic 
investigations are limited in most African countries, incidence reports are not fully certain. In 
addition, laboratory tests are used for diagnosis of PUD.Urea Breath Tests require the 
ingestion of urea labeled with the nonradioactive isotope carbon 13 or carbon 14 with 
Specificity and sensitivity approaching to 100%. Cost and inconvenience are disadvantages 
of this test. Stool Antigen test using monoclonal antibodies are as accurate as urea breath 
tests and it is cheaper also. But, like urea breath test, it detects only active infection. 
Serologic Antibody testing detects immunoglobulin G specific to H. pylori in serum since 
antibody can stay for long time in the body. But, this test cannot distinguish between an 
active infection and a past infection. Endoscopy with biopsy is recommended to rule out 
cancer and other serious causes especially in old patients. Culture and Polymerase Chain 
Reaction can allow for susceptibility testing but are not readily available for clinical use (27). 
1.1.4 Management of Peptic Ulcer Disease 
Based on the involvement of multiple factors in peptic ulcer, several therapeutic strategies 
have been adopted against it. These, include suppression of the aggressive factors with use of 
antacids, specific antagonists of muscarinic -M receptors, Gastrin receptors, Histamine-H2 
receptors, Proton Pump Inhibitors (PPIs), and mucoprotective agents, antimicrobials for 
eradication of H. pylori and analogues of prostaglandins. Researches for development of 
antiulcer agent, aims to address one or the other of these issues (28). 
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1.1.4.1 Non Pharmacological Approaches 
Several studies implied that modulating life style factors as dietary factors, controlling stress, 
reducing smoking, physical exercises and alcohol intake may directly prevent the initiation of 
gastric ulcers. Weight loss, avoid precipitants, raise the head of the bed, not eating late at 
night, stop NSAIDs/steroids, Diet therapy, caloric distribution, and micronutrients, such as 
vitamin A, Zinc, Selenium, and Vitamin C promote healing in especially during the recovery 
phase. In addition, vitamin C has a beneficial effect in eradication of H. pylori. Fibers and 
probiotics also play a role by reducing side effects of antibiotics and treatment time (29, 30). 
1.1.4.2 Conventional Anti-ulcer Agents 
The goals of treating peptic ulcer disease are to relieve pain, heal the ulcer and prevent ulcer 
recurrence (28).Antacids, H2-receptor antagonists are effective in healing both gastric and 
duodenal ulcers. PPIs (Omeprazole, Pantoprazole) inhibit gastric acid by blocking the 
H+/K+-Adenosine Triphosphatase enzyme system.PPIs are the most effective drugs to treat 
PUD. But,there are still areas of medical need in acid controls that are not met by PPIs as 
these drugs are slow to achieve steady state inhibition (typically take 3 to 5 days); Inter-
individual variations in efficacy due to CYP2C19 polymorphism and the requirement of meal 
time dosing to ensure adequate levels of the drug during periods of H+/K+-ATPase activation. 
In order to avoid the limitations encountered on PPIs, the search for new drugs is still an 
active area of scientific research. Such scientific researches end up with the development of 
more potent gastric acid suppressants called potassium competitive acid blockers (P-CABs) 
which have several advantages over PPIs as:P-CABs rapidly achieve therapeutic plasma 
levels and provide almost complete inhibition of gastric acid secretion; No inter-individual 
variation; P-CABs action is independent of secretory state;P-CABs are acid stable and do not 
require an enteric coating formulation. Some of these agents are, SCH28080, 
Revaprazan(only used in South Korea and India) and Vonoprazan (recently approved) in 
Japan (31). 
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Figure 1: Sites of action of drugs used to treat peptic ulcer disease(24). 
 
1.1.4.3 Miscellaneous Investigational Anti-ulcer Agents 
Currently, different studies have been undertaken to find an ideal investigational anti -ulcer 
treatment by various agents as  drugs of other uses, metabolic products, minerals and growth 
factors with different mechanism of actions (32).Tacrolimus has an ulcer protective activity 
through its anti-secretory, antioxidant and anti-inflammatory action and its inactivation of 
immune cells which binds to the FK506 binding protein and this complex interacts with 
calcineurin which inhibits the catalytic activity of calcineurin. Nitric Oxide (NO) inhibits 
gastric secretion by suppression of histamine release from Enterochromaffin-like Cells and 
inhibits platelet aggregation. Furthermore, NO and Peroxynitrite have a direct toxic effect on 
Potassium Competitive 
Acid Blockers 
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H. pylori VI strain. Copper, as a cofactor and a prosthetic component of several 
cuproenzymes controlling oxidation-reduction reactions including Cytochrome c- oxidase, 
Superoxide dismutase has ulcer protective effect. Recently, probiotics have been reported to 
have antiulcer effects especially those of Saccharomyces Boulardii yeast or lactic acid 
bacterial species which have ability to eradicate  H. pylori bacteria (33),protect gastric 
mucosal barrier, upregulate prostaglandins, mucus, growth factors and anti-inflammatory 
cytokines, Increase cell proliferation to apoptosis ratio and induce angiogenesis. In addition, 
some advanced procedures as Transplantation of bone marrow mesenchymal stem cells or 
possibly gastric epithelial stem cells are also a proposed for the treatment of gastric ulcers 
that requires further investigation (34).Carbon monoxide (CO) is also involved in the 
restoration of murine gastric epithelial cells, this is because of CO solution accelerates the 
gastric ulcer healing by promoting re-epithelialization and cell migration through the 
activation of protein kinase C (PKC) which is proposed to be a novel therapeutic approach 
for the treatment of gastric mucosal injuries in the future(32). 
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1.2 LITRATURE REVIEW 
 
1.2.1 Traditional medicines 
Peptic ulcer is one of the world’s major gastrointestinal disorders and affecting 10% of the 
world population and 75–80% of the world populations still use herbal medicine mainly in 
developing countries, because of better cultural acceptability and lesser side effects 
especially, The East African region is well known with plant biodiversity with an estimated 
of over 21 000 higher plant species. This provides Ethnopharmacologists for phytochemical 
and pharmacological studies (35) in different areas based on the plants phytochemical 
constituents and traditional claims as plant metabolites like Flavonoids and Tannins have  
active principles of antiulcer activity (36) by correlating the scientific world and the 
traditional medicine's close relation with the community’s health care system. Ethiopia is 
enriched in both medicinal plant biodiversity and cultural knowledge on ethno pharmacology 
of medicinal plants (37, 38) which are the integral part of the variety of cultures over 
centuries for human (39) and livestock medicines (40).In Ethiopia, where major way of 
indigenous knowledge transfer on medicinal plants, was by word of mouth to a family 
member,none of the traditional healers had written documents on traditional medicines 
(41).So, several ethno botanic studies  reported in different areas can play a great role for the 
documentation and preservation of medicinal plants and the knowledge itself as well as 
further  screening studies (42, 43). 
1.2.2 Herbal Medicines for peptic ulcer disease 
Large numbers of studies have been done on the relationship between plant extracts and their 
anti-ulcer activity on animal experimental models.Though selecting a suitable model been 
difficult as each model has its own advantages and disadvantages, one can select based on the 
resources and objectives of study. Generally, Pyloric Ligation, Alcohol induced ulcer, Cold 
stress induced ulcers and Indomethacine induced ulcer models are some of them. The plants' 
families majorly include; Moraceae (family of F.thonningii), Portulacaceae and Urticaceae 
(44).A medicinal plant, Ipomoea-batatas increased gastric anti-oxidant enzymes on asprine 
induced and cold stress induced ulcer models (45) Another medicinal plant Aloe vera was 
also reported gastroprotective activity on ethanol induced ulcer models (46) a single dose 
250mg/kg of Artocarpus Integrifolia screened by pylorus ligation model was reported 
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significant reduction of gastric juice volume,total acidity and pH with 50.9% reduction in 
ulcer index (47) a 100mg/kg,200mg/kg and 400mg/kg Centelia asiatica has been reported 
ulcer protecting effects on ethanol induced ulcer model (48) anti-ulcer effect of Citrullus 
colocynthis on pylorus ligation model was reported comparable with the standard drug 
ranitidine (49) there are many medicinal plant species studied in different ulcer models 
are:Ocimum sanctum(50);Glycyrrhiza glabraon (51);Hedranthera barteri (52);Ocimum 
suave (53);Swietenia mahagoni (54).F.sycomorus L.(55) and F.sreligiosa (56). 
1.2.2 The Experimental Plant: Ficus thonningii Blume (Moraceae) 
Ficus thonningii Blume also known as the common wild fig (Eng) is grouped in a family of 
Moraceae.It is a multi-stemmed, evergreen or briefly deciduous tree. It mainly distributes in 
upland forests of tropical and sub-tropical Africa. The bark is usually smooth, pale to dark 
grey with vertical lenticels and the tree usually has aerial roots that hang from 
branches.Globally,nearly 750 species of ficus were found (57).F.thonningii has been 
described as a complex of taxa under which F.rokko, F.rhodesiaca, F.burkei, F.petersii, 
F.persicifolia and a number of other Ficus species are all lumped (58).The different local 
names of the plant are: jammeiz al abiad (Arabic);India-laurel fig (French); mtschamwa 
(Swahili).In Ethiopia, F. thonningii is called shibaka (Tigrigna) and Chibha (Amharic)(59). 
 
Figure 2: Photograph of F.thonningii Blume Wild (Moraceae) 
F.thonningii has anti-malarial activity both in vitro and in vivo according to  the report in 
Nigeria (60).F.thonningii contains different classes of phytochemicals as: Flavonoids, 
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Tannins, Soluble starches,Glycosides,Alkaloids, Terpenoids and Essential oils  on the 
stem,bark, leaves and roots. Furthermore, identified chemicals as orientin, vitexin and 
isovitexin and stilbenes which include resveratrol, resveratrol glucosides and stilbenes 
glucosides which have anti-ulcer activities are also identified (58). 
F. thonningii is extensively used by ethno medical practitioners for treating various ailments 
in Africa including analgesic, antimicrobial, anti-helmintic, antioxidant, cardio protective, 
hypotensive and hypoglycemic effects of the plant extracts. In addition, it is used for 
infertility, impotence, yellow fever, loss of appetite (root), diarrhea (chewing the root), and 
stomachache (chewing the inner bark).In Nigeria, a maceration of the leaves is used for 
treating stomach pains, gastritis, gastric ulcers and colitis. Traditionally, the stem bark is 
pound and the infusion is used for treating influenza, sore throat, colds, arthritis, rheumatism 
and to relieve inflammation (61). 
F. thonningii stem bark decoction is also used in Mali and Senegal, to treat respiratory 
diseases such as;pneumonia, bronchitis, emphysema. and for treating diarrhea, cysts, skin 
diseases and ulcers in Ethiopia (59).In addition, F. thonningii exhibit trophic developmental 
changes on the neonatal gastric tissues without any adverse effects (58). 
1.3 JUSTIFICATION OF THE STUDY 
Globally, Peptic ulcer accounts approximately 1% mortality (23). In many poor countries, 
expenditures for drugs range from 20% to 60% of total budget on health. Drug resistance has 
also a startling impact on the cost of curing patients(62).Due to this, catalyze research and 
innovation to speed the development of resistance-fighting technologies has been set as a 
recommendation. The rise of resistant strain of H.pylori on different Antimicrobials 
especially in developed countries has been given great attention (63).Patients on once daily 
doses of PPIs failed at a rate of 56% Which indicates  significant PPI drug resistance and 
rapid  metabolism due to CYP2C19 polymorphism (64, 65). 
The expected increase in the cost of commercial drugs and side effects of drugs as 
Cardiovascular,Endocrine,and Sedative effects, complexity of administration,drug-drug and 
drug-food interactions generally leads to find new chemicals for ulcer treatment (66).The 
search for new drugs species have been going on. Availability of secondary metabolites 
which have anti-ulcer activities indicates the anti-ulcer potential of F.thonningii that is 
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repeatedly reported throughout different parts of the world but no report was made on the 
antiulcer activity of hydro methanolic and solvent fractions of the stem bark of the plant. Due 
to this, the study was done and verified the claims of the previous reports on the knowledge 
of native traditional medicine practitioners. 
The finding of this experimental study helps the scientific community to further investigate 
on this medicinal plant by initiating advanced studies on formulations and molecular 
mechanisms of plant source drugs and by isolating a specific antiulcer compound. 
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2. OBJECTIVES 
2.1 General Objective 
To evaluate the antiulcer activity of Hydromethanolic crude extract and solvent fractions of 
the stem bark of F. thonningii (Moraceae) on rodent models. 
2.2Specific Objectives 
 To undertake preliminary phytochemical screening on F. thonningii stem bark. 
 To evaluate anti-ulcer effect of Hydromethanolic extract of F. thonningii stem bark 
on the dose dependent pyloric ligation ulcer model. 
 To evaluate the time dependent anti- ulcer effect of Hydromethanolic crude extract 
and solvent fractions of F. thonningii stem bark on ethanol induced ulcer model. 
 To determine acid reduction ability of the crude and solvent fractions of bark of F. 
thonningii plant extract using colorimetric and titrimetric analysis. 
 To evaluate the ulcer healing effect of crude extract on indomethacine induced ulcer 
model.  
 To determine the acute oral toxicity effect of Hydromethanolic extract of the stem 
bark of F.thonningii 
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3. MATERIALS AND METHODS 
3.1 Materials 
3.1.1Equipments, Drugs, Chemicals and Supplies 
Methanol (ReAgentchem.Ltd;India),n-hexane (bululuxlab),Chloroform (NICELab.),Distilled 
water,Dethylether(BlululuxLab.),0.1NNaOH(CentralDrugHouse,India),HCl,sulfuricacid,Twe
en 80 (Bululux;Lab.),Phenolphthalein (RFCL;RANKEM,India),Analytical graded 
Balance,Lenses (10X),pH meter,Absolute Ethanol (96%)(Bululux lab.),Mayer’s 
Reagent,Normal Saline ,Ranitidine (ACILOC,Cadila;Ethiopia),Misoprostol 200 mcg tablet 
(Jai Pharma Ltd),10% buffered formaline.Mayer's reagent (Mettle-Toledo Ltd, 
Switzerland),Glacial acetic acid (Lobe chemi, India),2% Ferrous and Ferric Chloride,10% 
NaOH,Conc.H2SO4,diluted Ammonia. Filter paper (Watt man no.1EXACL; India).All 
chemicals were analytical grade purchased from Pharmaceutical Fund and Supply 
Agency,Gondar-Ethiopia,and obtained from Department of Pharmaceutical 
Chemistry,Pharmacognosy and pharmacology, University of Gondar. 
3.1.2Collection of Plant Material 
Stem bark of F. thonningii was collected from the local area of Gondar City Ethiopia, in 
January 2017.The plant was duely identified and authenticated by a Botanist and specimens 
were deposited at the herbarium in University of Gondar with voucher number of 
(HA001).The collected plant bark was washed immediately with running water and shade 
dried at room temperature, powdered mechanically and become ready for extraction. 
3.1.3 Experimental Animals 
White Swiss albino Mice (20-38mg) and Wistar Rats (150 – 250g) of either sex were used in 
this experiment. Animals were obtained from animal houses of departments of pharmacology 
and faculty of Veterinary Medicine University of Gondar, and National Veterinary Institute 
Bishoftu, Ethiopia. Animals were housed in standard cages at room temperature and 12:12 
hours of light dark cycle. Animals were fed with standard pellet diet and water ad libitum. 
Experimental protocol for care of animals was undertaken as per guidelines for use of 
laboratory Animals (67). 
14 
 
3.2 Methods 
3.2.1 Preparation of Hydromethanolic Bark Extract 
The stem bark of F. thonningii was shade dried and reduced to coarse powder then grinded to 
coarse powder using mortar and pestle. 1 kg of the powdered material was first extracted by 
maceration with an Erlenmeyer flask using 80% Methanol in distilled water for a period of 3 
days with occasional shaking. Then, the extract was initially filtered by gauze (muslin) and 
re-filtered by electrical sucker using filter paper (whatman no.1, UK). The marc was re-
macerated for the second and third times with fresh hydro alcohols, for a total of 9 days. 
After filtration, the three extracted solutions were combined and concentrated in hot air oven 
adjusted to a temperature of 40 0C. In addition, Rotary evaporator (RE200, Germany) was 
used under reduced pressure to concentrate and separate methanol from the distilled water in 
department of Organic Chemistry, University of Gondar. It was then put into desiccator to 
prevent moisture absorption. The crude extract was used for acute toxicity, preliminary 
phytochemical screening and anti- ulcer activity testing (68). The percentage yield of crude 
extract was calculated as: 
Percentage yield = (Weight of extract/Weight of sample) X 100 
3.2.2 Fractionation 
N-hexane, Chloroform and distilled water were used as solvents for fractionation. Selections 
of organic solvents were carried out based on their increasing polarity index and 
immiscibility with water. Half of the above 80% hydro methanolic extract was used. First, 68 
grams of the crude extract was weighed and dissolved in 200 ml of distilled water. Then the 
suspension was poured in to a separatory funnel. Then, by adding 150 ml of n-hexane each 
time 3 times, the mixture was shaken and filtered to obtain the n-hexane fraction. The density 
of n-hexane is less than water and so formed the top phase. Likewise, 150 ml of chloroform 
was added and shaken gently. Because the density of chloroform is greater than water and 
also immiscible, it forms two phase with the bottom for chloroform fraction and the top for 
aqueous phase. Chloroform was added three times and filtered to obtain the chloroform 
fraction. The final marc left after was filtered and aqueous fraction was taken. Then, all 
fractions were concentrated in hot air oven adjusted to a temperature of 40°C (69) to remove 
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the solvents. all fractions were placed in a desiccator. Finally, the dried fractions of each 
solvent were collected except the n-hexane fraction which was not sufficient for further tests. 
3.2.3 Phytochemical Screening 
Preliminary Phytochemical screening tests was carried out to determine the major classes of 
phytochemicals on crude extract of F. thonningii stem bark by using different standard test 
procedures(70-72). 
Terpenoids: Salkowski’s test: 2 ml of chloroform was added to 0.5 g of plant extracts and 3 
ml of concentrated sulphuric acid resulting in the formation of two layers. A reddish brown 
color at the interface of these layers should be shown for confirmation of the presence of 
Terpenoids. 
Saponins: Froth test: A milliliter of plant extract filtrate has been shacked in 10 ml of 
distilled water for 30seconds.a Persistent frothing indicated the presence of Saponins.  
Flavonoids: Ferric Chloride test: in the presence of Flavonoids, few drops of ferric chloride 
solutionon the Test solution will show intense green color. 
Test for Tannins: The plant extract was stirred with 2 ml of distilled water and filtered with 
filter paper (What man No. 1) few drops of 2% ferric chloride were added to the clear filtrate. 
Then, the filtrate was observed when it gives a green precipitate indicating the presence of 
tannins. 
Tests for Steroids;2ml extract was dissolved in 2 ml of chloroform & equal volume of 
concentrated H2SO4 acid was added from the side of test tube .a red color formed in the 
lower chloroform indicates the presence of steroid (70). 
Identification test for alkaloids:  Few drops of Mayer’s reagent were added to1 ml of the 
powder of plant extract. a whitish opalescence precipitate with Mayer’s reagent indicated the 
presence of alkaloids(71). 
Phenolic compounds: Ferric chloride test: Small amount of extract/fraction was dissolved in 
distilled water and to this few drops of neutral 5% ferric chloride solution was added. 
Formation of blue  green color indicates the presence of Phenolic compounds(72). 
Test for Glycosides: keller-killiani test:1 drop of ferric chloride was added on 2 ml crude 
extract and 2 ml glacial acetic acid. The mixture was then poured in to a test tube of 1 ml 
conc.H2SO4. Formation of a brown ring indicates the presence of glycosides. 
16 
 
Test for Anthraquinones: 3 ml of the plant extract was dissolved by benzene and filtered 
with watt man filter paper .Then 2 ml of Ammonium hydroxide was added. Formation of 
purple ring indicates the presence of Anthraquinones. 
3.2.4 Acute Toxicity Test 
Acute toxicity study was carried out using the guidelines described by OECD-425 ((67).Five 
female albino mice were selected Randomly and fasted for 4 hrs but  water was allowed. A 
limit dose 2000 mg/kg of F.thonningii Stem bark crude extract was administered sequentially 
for three mice and animals were observed individually for behavioral profile (alertness, 
restlessness, irritability and fearfulness), autonomic profiles (defecation and urination), 
neurologic profile (spontaneous activity, reactivity, touch response, pain response and gait), 
physical states as  lacrimation, loss of appetite, tremors, hair erection, salivation, diarrhea and 
for morbidity or mortality after dosing continuously for two hours, periodically during the 
first 24 hours  and daily thereafter. Body weight of the five mice was measured initially at the 
time of administration, at the seventh and fourteenth day of administration with the 
remaining two controls. Since all three  animals were survived, the LD50 is greater than the 
limit dose and the test was terminated (i.e. carried to full 14-day observation without dosing 
of further animals) (67). 
3.2.5 Grouping and Dosing of Animals 
The anti-ulcer activity of F.thonningii was studied using three experimental models of ulcer 
and grouping of animals was done randomly to different groups each consisting of six 
animal. The test groups received different doses of the plant extract. The negative control 
groups were treated with solvents of the extracts only while the positive control groups were 
treated with Ranitidine 50 mg/kg and Misoprostol 5µgm/kg.Animals which came from other 
places were allowed to acclimatize to the laboratory conditions for one week and had free 
access to tap water and Normal Pellet Diet (NPD) until they were assigned to individual 
groups. 
3.2.5.1 Pylorus Ligated Induced Ulcer model 
The shay rat model with some modification which was  used by previous studies was applied 
(47, 73).Rats were randomly divided into five study groups, each consisting of six animals.  
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Group 1 was the negative control group, which was received vehicle only (distilled water + 
6% Tween 80). Group 2 was served as a positive control and rats ware pretreated with 
Ranitidine 50 mg/kg for ten days. Groups3, 4 and 5 were received100, 200 and 400 mg/kg of 
hydromelthanolic extracts of F.thonningii.  
During the study, rats were fasted for 24 h before the study, but had free access to water till 
the last 4 hours. After 1h of the last drug treatment, animals were anaesthetized inhalationally 
with diethyl ether and the abdomen was opened by a small midline incision below the 
xiphoid process. Pyloric portion of the stomach was lifted out and ligated carefully to avoid 
traction to the pylorus or damage to blood supply of gastric mucosa. The stomach was 
replaced carefully and the abdominal wall was closed by interrupted sutures. After four hours 
of pyloric ligation, Rats were sacrificed by inhalational anesthetic ether. The abdomen was 
opened, cardiac end of the stomach was dissected out and the content was drained into a test 
tube. The gastric juice was collected and centrifuged at 1000 rpm for 10 minute the volume 
of the supernatant was noted and taken for the determination of Total acidity and pH.The 
stomach Mucosa of each animal was washed with saline and running water, labeled and 
placed on sodium phosphate buffered 10% formalin until it was examined for lesions by 
using hand lens (10X) and scored accordingly. 
3.2.5.2 Ethanol-Induced Ulcer Model 
The ulcer was induced by administering ethanol following the method by Hollander D. et al 
(74) and previous studies to determine the anti-ulcer effect of repeated and single dose 
administration with some modifications (75, 76).Animals were randomly assigned to 10 
groups each consisting six Animal. Group 1and 6  received the vehicle (distilled water+4% 
Tween 80 for single dose and repeated dose for 10 days respectively) and considered as a 
negative control, whereas groups 2 and 7 were served as a reference standard and  pretreated 
with Misoprostol 5µg/kg (single and repeated for 10 days respectively). Groups 3, 4 and 5 
were treated with 200 mg/kg (crude, chloroform and aqueous fractions in single dose 
respectively) and 8,9 and 10 were pretreated with 200 mg/kg of crude extract, chloroform 
and aqueous fractions of F.thonningii for 10 days respectively. Animals were fasted for 24 
hours before administration of Ethanol. All pretreatments of the last dose were given orally 
one hour before the experiment. Gastric ulcer was induced after 60 min of  F.thonningii in 
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200mg/kg doses and Misoprostol 5µg/kg treatment by administering ethanol (90%%w/v) at a 
dose of 1ml/200g body weight (0.2ml) to each animal and after 1 hr, animals were scarified 
with spinal dislocation; stomach was incised along the greater curvature and ulceration was 
scored similar to PL (77). 
3.2.5.3 Ulcer healing effect on Indomethacine Induced Ulcer 
This test was the first to study ulcer healing effect on since there was no well-studied model 
for ulcer healing study  the protocol of P.Guha et al (78) was followed for ulcer induction , 
ulcer was induced with Indomethacine (18mg/kg) in order to evaluate the ulcer healing effect 
of the plant extract which was compared with negative control (vehicle) and 
positive(Misoprostol 5µgm/kg) treated groups. The treatment groups received CEFT 
100,200,400 mg/kg (once daily). The first dose was given 6 h after induction of ulcer with 
indomethacine (18 mg/kg). Four days after ulcer induction, analysis has been done. 
3.2.6 Parameters for Evaluation of Antiulcer Activity 
3.2.6.1 Macroscopic Evaluation of Stomach 
The stomach was  opened along the greater curvature, rinsed with saline and running water to 
remove gastric contents and blood clots then the mucosa of each animal was labeled and 
placed on sodium phosphate buffered 10% formalin until it will examined by a 10Χ 
magnifier lens to assess the formation of ulcers. The numbers of ulcers was counted. Scoring 
of ulcer was based on the method by Kulkarni (79) as: 
Normal colored stomach............. (0) 
Red coloration............... (0.5) 
Spot ulcer............…. (1) 
Hemorrhagic streak... (1.5) 
Deep Ulcers....................… (2) 
Perforation.............… (3) 
Mean ulcer score for each animal will be expressed as ulcer index.  
Ulcer index (UI) was measured by using following formula:  
UI = UN + US + UP Χ 10-1 
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Where,UI= Ulcer Index; UN = Average number of ulcers per animal; US =Average number 
of severity score; UP = Percentage of animals with ulcers (73). 
Percentage inhibition of ulceration will be calculated as below: 
% Inhibition of Ulceration = (Ulcer index Control -Ulcer index Test) × 100 
                                                                  Ulcer index Control 
% Protective ratio=100-(UI pretreated)x100 
                                    (UI Control) 
% Curative ratio=100-(UI Treated)x100 
                                (UI Control) 
3.2.6.2 Determination of pH and Gastric Volume 
An aliquot of gastric juice was taken and pH of the solution was measured using pH meter 
based on the method of Tan (54). The volume of Gastric Juice of each animal was measured 
after centrifugation with 1000 rpm for 10 minutes and analyzed since it is one parameter for 
the study of the anti-secretory effect of the plant extract. 
3.2.6.3 Determination of Total Acidity 
An aliquot of 1ml gastric juice diluted with 9 ml of distilled water was taken and two drops 
of phenolphthalein indicator was added. Then, it was titrated with 0.01N NaOH until a 
permanent pink color was observed. Based on the volume of 0.01N NaOH consumed, The 
total acidity was expressed as mEq/L by the following formula (54): 
Total Acidity = Vol. of NaOH × N × 100 mEq/L 
0.1 
3.2.7 Data quality control 
The data quality was maintained by simple randomized grouping of animals; blinded data 
collection system of all parameters; maintaining and applying standard procedures and using 
analytical graded products. 
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3.2.8 Data Analysis 
SPSS version 20 was used for data entry, coding, cleaning and analysis of results. The result 
was expressed as the mean ± SEM for each parameter. Statistical differences were evaluated 
using a one-way Analysis of Variance (ANOVA) followed by post hoc Tuckey's multiple 
comparison tests. Student Paired t-test was also used to compare parameter results between 
single and repeated administration of the same doses. Results were considered to be 
statistically significant at (P<0.05). 
3.2.9 Ethical Clearance 
Ethical clearance was obtained from research and ethics committee, department of 
pharmacology, University of Gondar with Reference number of SOP4/76/09.All  
procedure done on animals were done based on the rules and regulations set by a Guide 
for the Care and Use of Laboratory Animal (80). 
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4. RESULTS 
4.1. Percentage yields of crude extract and fractions 
The 80% hydromethanol stem bark extract of F.thonningii was a dark brown solid, while the 
chloroform fractions was a greenish black paste and the aqueous fraction reddish brown 
paste, a small greenish layer was observed on the foor of the beaker of N-hexane fraction. 
The percentage yields of the crude extract and solvent fractions are shown in Table 1. 
Table 1- Percentage yield of F.thonningii stem bark extract (1000 gm) 
Extract Yield (gm) Percentage yield 
Crude extract 135/1000 gm bark 13.5 %;w/w 
Aqueous fraction 12.0/67 gm crude 17.91 % 
Chloroform fraction 5.5/67 gm crude 8.2 % 
N-hexane fraction --- Very small 
 
4.2 Preliminary phytochemical screening 
The crude bark extract of F.thonningii contains secondary metabolites shown on table 2 
Table 2-Preliminary phytochemical screening of F.thonningii stem bark 
Test Phytochemical Result 
1.  Terpinoides YES 
2.  Saponins YES  
3.  Alkaloids YES  
4.  Tannins YES 
5.  Plant steroids NO 
6.  Anthraquinones YES 
7.  Glycosides YES 
8.  Phenolic compounds  YES 
9.  Flavonoids YES 
          
4.3 Acute Oral Toxicity Studies 
The crude extract of F.thonningii stem bark administered up to 2000 mg/kg did not cause any 
mortality in mice. None of the animals tested produced any gross apparent effect on general 
motor activity, muscular weakness, fecal output and feeding behavior during the period of 
observation. 
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4.4 Anti-ulcer Results 
4.4.1 Effects of Crude Extract of F.thonningii on Pylorus ligation-induced ulcer 
A dose dependent significant reduction in volume of gastric juice on CEFT100 mg/kg 
(P<0.01), CEFT200 and CEFT400 (P<0.001) was found and Total acidity was reduced 
significantly (P<0.001) for all three doses compared with the negative control. (Table- 3). 
Table 3-Anti -ulcer (anti secretory) effect of crude extract of F.thonningii on pylorus ligated induced 
ulcer model 
Group Treatment  Dose(mg/kg) Volume of gastric 
juice 
 Reduction 
of vol. (%) 
Total  Acidity  Reduction in 
acidity (%) 
I vehicle only _  5.91±0.62 -  51.66±3.07 - 
II F.thonningii 100mg/kg  2.61±0.81a2 55.8  30.00±2.58
a3 41.9 
III F.thonningii 200mg/kg  1.92±0.24a3 67.5 23.33±2.10 a3 54.8 
IV F.thonningii 400mg/kg  2.16±0.30a3 63.4  23.33±3.07
a3 54.1 
V Ranitidine 50mg/kg  0.60±0.13a3 89.8  21.66±3.07
a3
 58.1 
Note: Values are expressed as Means ± S.E.M (n=6),2=P<0.01, 3=P<0.001 a=compared with 
negative control group(95% CI) Statistical comparisons are significant at P-Value<0.05 
 
Gastric pH and Ulcer Index 
The two doses, CEFT 200 and CEFT 400 significantly Increased the gastric pH (P<0.05) and 
reduce UI (P<0.05) compared to the negative control group. Extracts decreased the UI in a 
dose dependent manner and CEFT 200 and CEFT 400 reduced percent of UI more than the 
standard drug (Ranitidine) as shown in (Table-4). 
Table 4-Effect of crude extract of F.thonningii on pH and ulcer index on PL Rats 
Group Treatment Dose PH Ulcer Index(UI) Reduction in 
Ulcer Index 
(%) 
I Vehicle -  3.16±0.16  15.93±0.79 - 
II F.thonningii 100mg/kg  4.50±0.34  10.58±2.14 33.6 
III F.thonningii 200mg/kg  5.13±0.61
a1
  6.12±2.74
a1
 61.6 
IV F.thonningii 400mg/kg  5.00±0.51a1  6.04±2.7a1 62.0 
V Ranitidine 50mg/kg  5.37±0.30a1  8.20±2.60  48.5 
 
Note: Values are expressed as Means± S.E.M (n=6)1= P<0.05, a=Compared with negative control, 
 (95% CI)  Statistical comparisons are significant at (P<0.05) 
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4.4.2 Effect of F.thonningii 200 mg/kg on Ethanol induced ulcer 
4.4.2.1 Single dose administration 
No significant reduction of the ulcer score and ulcer index for all fractions of the same dose. 
Misoprostol 5µg/kg had reduced UI significantly (P<0.05).The percent reduction in UI was 
59.1%, 43.76%, 59.0%, 73.34% for the crude, chloroform, aqueous fractions and the 
standard drug respectively. 
Table 5-Effect of crude and solvent fractions of FT 200 mg/kg on ethanol induced ulcer 
model (single dose) 
Group Treatment  Dose(mg/kg) Ulcer Score (US) Reduction 
US (%) 
Ulcer Index(UI)  Reduction 
in UI (%) 
I Vehicle(dist.water+6%
Tween80) 
_  0.84±0.14 -  14.67±0.99 - 
II F.thonningii(Crude) 200mg/kg  0.33±0.17 60.7  6.0±2.68 59.1 
III F.thonningii(Chlorofor
m Fraction) 
200mg/kg  0.58±0.24 30.9 8.25±2.61  43.76 
IV F.thonningii(aqueous 
Fraction) 
200mg/kg  0.58±0.30 30.9  6.08±2.72 59.0 
V Misoprostol 5µg/kg  0.25±0.17 70.24  3.91±2.47a1 73.34 
 
Note: Values are expressed as Mean ± S.E.M (n=6) 1=P<0.05;a=Compared with vehicle (95% CI) 
Statistical comparisons are significant at (P<0.05) 
4.4.2.2 Repeated dose administration 
Both the Hydromethanolic and aqueous fractions reduced UI significantly (P<0.05).while 
chloroform fraction did not show significant reduction in UI(P˃0.05).The percent reduction 
in UI was 39.76%,70.76%,71.86%,72.96% for chloroform fraction, aqueous fraction, crude 
extract of F.thonningii and Misoprostol(standard) on respective ascending orders.(Table-6). 
Table 6-Effect of crude and solvent fractions of FT 200mg/kg on ethanol induced ulcer (10 days) 
Group Treatment  Dose(mg/kg) Ulcer Score (US) Reduction US 
(%) 
Ulcer Index(UI)  Reduction in UI 
(%) 
I Vehicle(dist.water+6
%Tween80) 
_  0.73±0.08 -  15.39±0.72 - 
II F.thonningii(Crude) 200mg/kg  0.5±0.31 31.50  4.33±2.74a1 71.86 
III F.thonningii(Chlorof
orm Fraction) 
200mg/kg  0.61±0.27 16.43 9.27±2.98  39.76 
IV F.thonningii(aqueous 
Fraction) 
200mg/kg  0.5±0.31 31.5  4.5±2.8a1 70.76 
V Misoprostol 5µg/kg  0.33±0.24 54.8  4.16±2.6a1 72.96 
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Note: Values are expressed as Mean ± S.E.M (n=6) 1=P<0.05;a=compared with vehicle group, (95% 
CI ) Statistical comparisons are significant at (P<0.05) 
There was no statistically significant deference on US and UI between single and repeated 
dose of the same group when analyzed by paired-sample T-test for all fractions. 
4.4.3 Assessment of healing on Indomethacine Induced ulcer  
There was a dose dependent reduction UI (61.72%.61.15%,63.35%;for CEFT 100, 200,400 
mg/kg respectively) but no significant reduction on US and UI for CEFT 100,200 and 400 
mg/kg except Misoprostol (P<0.05) (table-7). 
Table 7-Ulcer healing effect of CEFT100, CEFT200 and CEFT400 on indomethacine 
induced ulcerated mice (4 day treatment) 
Group Treatment  Dose(mg/kg) Ulcer Score (US) Reduction US 
(%) 
Ulcer Index(UI)  Reduction in UI 
(%) 
I Vehicle(dist.water+6%
Tween80) 
_  0.65±0.15 -  10.45±2.1 - 
II F.thonningii(crude) 100 mg/kg 0.16±0.10 75.4 4.00±2.50 61.72 
III F.thonningii(Crude) 200mg/kg  0.25±0.17 61.5  4.06±2.58 61.15 
IV F.thonningii(Crude) 400mg/kg  0.16±0.10 75.4 3.83±2.42 63.35 
V Misoprostol 5µg/kg  0.00±0.00a* 100  0.00±0.00a* 100 
 
Note: Values are expressed as means ± S.E.M (n=6)*P<0.05; a=Compared with negative control 
group; (95% CI) Statistical comparisons are significant at P-Value<0.05 
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5. DISCUSSION 
This study has been done to evaluate the anti-ulcer effect of F.thonningii stem bark 
considering the global prevalence of the disease and the little attention given to search novel 
antiulcer agent. the 80% Hydromethanolic solvent is the most preferred one to dissolve both 
polar and non-polar phytochemicals since many organic substances  are not extracted from 
aqueous solvents only (81). 
The present study’s Preliminary Phytochemical screening result revealed presence of: 
Tannins,Saponin, Anthraquinons,Terpinoids,Phenoliccompounds, Flavonoids and cardiac 
glycosides the result was coherent with reports of other Pharmacological researches in 
Zimbabwe and Nigeria(58, 61).However the phytochemical result of this study was  in 
contrast with the taxonomical report in Nigeria (82). The difference may be due to the aim of 
the research, the solvents used, soil or climatic factors. methanolic extract of stem bark of 
F.sycomorous which is grouped in the same family (Moraceae),had the above metabolites 
and absence of plant steroids (70). 
The above phytochemicals in the study plant have anti-ulcer  activity especially Phenolic 
compounds and Flavonoids that possess an ideal structural chemistry for free radical 
scavenging and Antioxidative properties. As known, this effect when combined with 
endogenous gastric peroxidases,can reduce free radical accumulation and prevent oxidative 
mucosal damage. The effect may arise from their high reactivity as electron donors (83) 
Saponins have anti-ulcer  action by mediating the formation of mucous (84).Tropane 
alkaloids(Anisodamine and anisodine) which are analogs of atropine block the muscarinic 
activity of acetylcholine and show antisecretory effect.Quinolizidine alkaloids (matrine, oxy-
matrine) and Indole alkaloids (Nigakinone and methylnigakinone) have reported antiulcer 
effects by decreasing the gastric acid/pepsin secretions and increase the protection of the 
mucous membrane (85).Flavonoids can also increase mucosal prostaglandin, decrease 
histamine secretion by the inhibition of Histidine Decarboxylase,improve mucus secretion 
and inhibition of H. pylori growth. Tannins can prevent ulcer  by improving vasoconstricting 
effects (86) and they have astringent properties by reacting with the layer proteins and are 
known to ‘tan’ the outermost layer of the mucosa  to render it less permeable to chemical 
injury or irritation and Saponins activate mucous membrane protective factors(87).The study 
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plant was rich on the above mentioned phytochemicals and anti- ulcer effect might be due to 
the presence of one or more of these secondary metabolites.  
The models for the present study have been selected based on the multiple Pathophysiology 
of PUD considering Central and peripheral factors (23, 88) as well as the actions of 
prostaglandins on the disease (23).Pylorus ligation (surgical),an exogenous ulcerogen, 
ethanol (chemical) and prostaglandin synthesis inhibiting, indomethacine (pharmaceutical) 
had been selected. In  pyloric ligation,the principle of ulcer formation is: accumulation of 
gastric juice and pepsin which involve in the auto-digestion of gastric mucosa implicated to 
ulcer incidence (52). Stress due to distension of stomach tissue increases gastric acid 
secretion and/or stasis of acid and fluid increases volume of secretion which is also an 
important factor in the formation of ulcer due to exposure of the unprotected lumen of the 
stomach by the accumulated acid. This model is simple, reproducible and highly predictable 
which never utilizes  exogenous ulcerogen and suitable for evaluation of antiulcer drugs with 
anti-secretory mechanisms (73).The present study showed a significant dose dependent 
reduction in volume of gastric juice on CEFT100 mg/kg (P<0.01), CEFT200 and CEFT400 
(P<0.001) as compared with the negative control. Result was comparable to the standard 
drug Ranitidine 50 mg/kg. With percent reduction in gastric volume of (55.8%, 67.5%, 
63.4% in respective doses vs 89.8% standard. Ulcer Index in the negative control group was 
almost similar with other studies of the same procedure(49, 77) indicating that the study was 
done according to the standard procedures. While gastric juice volume was lower (5.91 ml 
versus 8.1ml) this deference may be due to the time of administration (1 hr versus 45 
minutes)  which is related with onset of action of phytochemicals.  
All the three doses CEFT 100, CEFT200, CEFT400 significantly decreased total acidity 
(P<0.001).The study result confirmed the literatures’ reports as even complete elimination of 
acid secretion and the concept of mucosal cytoprotection (23). The  dose dependent antiulcer 
activity was further supported by ulcer index on CEFT 200 and CEFT 400 (P<0.05) while 
CEFT 100 and even ranitidine 50 mg/kg did not have significant effect on UI(P˃0.05) though 
it reduces acid secretion significantly.From this result one can see that antisecretory drugs 
only or acid suppressive therapies may not be necessarily effective on the rate of tissue 
regeneration (23) as this scenario of ranitidine was reported on previous studies (49) there 
was also significant change in pH (P<0.05) on CEFT200 and CEFT400  (76).This effect 
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suggests that the extract's anti-ulcer effect is mainly due to its antisecretory in complement 
with cytoprotective effect or mucosal tissue regeneration of the plant  due to presence of the  
active  Phytochemicals.  
No significant reduction of the  ulcer index for all fractions in Single dose treatment (P˃0.05) 
on ethanol induced ulcer. 
While, repeated doses of crude extract(200 mg/kg) showed better reduction in UI(59.1%  for 
1 day and 71.86% for 10 days compared to their respective negative control 
groups);chloroform fraction of F.thonningii (200 mg/kg) reduced  UI (43.76 %  for 1 day and 
39.76% for 10 days) and the aqueous fraction (200mg/kg) reduction in UI (59 %  for 1 day 
and 70.76% for 10 days).Repeated doses of crude extract and aqueous fractions have shown a 
statistically significant reduction in ulcer index (P<0.05) equivalent with Misoprostol 
(72.96%) the present study was coherent with the report of the same family plant 
F.arnottiana methanolic leaf extract 500 mg/kg for 10 days in Portugal, with reduction in UI 
of 63% (89).The present study  also affirms the importance of repeated dose administration 
reported by previous studies (75, 76).The study justified the pharmacokinetic concept of the 
active principle that the plant extracts having active ingredient need a repeated dose 
administration to attain its therapeutic window and steady state for ulcer protective effect.   
 From different solvents point of view, hydromethanolic extract and aqeoues fractions  have 
showed a statistically significant reduction on ulcer index (P<0.05).While Chloroform 
fraction of FT200 did not (P˃0.05) (Table-5).From this finding we can conclude that 
phytochemicals found in F.thonningii which have mucosal cytoprotective activity can be 
solublized by relatively polar solvents (water, methanol) than weakly polars (chloroform) as 
anti-ulcer effect of the aqueous leaf extract  was also reported by other study(90). 
Ethanol-induced ulcers in mice are characterized by heavy bleeding since it can cause 
immediate stasis in the blood flow (91) Studies show that (50%w/v) ethanol can induced 
gastric damage in ˃90% of test animals (92) and lesions are blackish of varying size parallel 
to the major axis. Lesions can be inhibited by various drugs like Misoprostol.since ethanol 
can cause turbulences in gastric secretion, alter in the permeability of the gastric membrane, 
free radical production during its metabolism as oxygen derived free radicals have been 
found in the mechanism of acute ulceration in the gastric mucosa leading to increased 
intracellular membrane permeability to sodium and water and enormous intracellular increase 
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of calcium that corresponds to the pathogenesis of gastric mucosal injury (93).plant 
principles which prevent ulcer can have cytoprotective effects in general. 
The result  on ulcer healing effect showed all doses (CEFT100, 200,400 mg/kg) did not have 
significant effect (P˃0.05).Here many things can be rised starting from the ulcer induction 
protocol as: indomethacine at 18 mg/kg cased ulcer score of 0.65±0.15;which was lower as 
compared with the  report done in Addis Ababa university ( dose 28 mg/kg ;ulcer 
score;1.83±0.17) (88).Meanwhile, a dose-dependent anti- ulcer  activity was recorded in the 
indomethacine model which indicated the plants low potency on ulcer healing effect that may 
need a higher dose to produce full protection against the ulcerogenic effect of 
NSAIDs.Simiar study on The plant Dialium guineense reported that antiulcer effect recorded 
only by the highest dose of 750 mg/kg (94). 
As known,inhibition of prostaglandin synthesis by blocking the enzyme cyclooxygense 
(COX) with NSAIDs which are the second most common etiologic agents of ulcer next to 
H.Pylor,can increase susceptibility  of GI mucosa by luminal irritants,  alter the micro 
circulation that is critical to the pathogenesis of ulceration and has negative impact on mucus 
and bicarbonate secretion (95).The present study result we can also lead to suggest that,either 
the anti-ulcer activity of  F.thonningii may not be related with modulation of prostaglandin 
synthesis or non selective inhibition of the constitutive enzyme COX-1 to an inflammatory 
enzyme( COX-2) as inhibition of COX-1 can delay healing by reducing platlates aggregation 
and even it can cause mucosal bleeding. this assumption was set from the report on anti-
inflammatory and prostaglandin inhibition activity of the plant (61) eventhough  ulceration 
could be  induced at day 4 after induction with indomethacine 18 mg/kg (78),higher than this 
dose might be used  as a protocol for ulcer healing study. This test was the first to study ulcer 
healing effect by treating animals after induction of ulcer we tested the protocol since there 
was no well-studied model for ulcer healing study. 
 Hydromethanolic extract of F.thonningii bark did not show any sign of acute toxicity up to 
2000mg/kg suggesting that stem bark of the plant is relatively non-toxic and same result has 
been reported on the leaf extract of F.thonningii in Nigeria by other studies(61, 96) and fruit 
is reported as edible in the study area(97). 
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6. CONCLUSION 
The present study demonstrates that the crude extract and aqueous solvent fraction of the 
stem bark of F.thonningii has an anti-ulcer effect, which may probably be related to the anti-
secretory, mucosal protecting, anti-inflammatry or free radical scavenging activity of the 
phytochemical constituents reported. This study justifies the traditional claims on the folk 
medicine reported in Ethiopia and Nigeria. This plant extracts also exhibited safety profile at 
the maximum dose of 2000 mg/kg. Therefore, the aqueous fractions and Hydromethanolic 
extract could represent a new source for the development of new plant based antiulcer agent. 
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7. RECOMMENDATIONS 
Pharmacological Screening studies are bases for the progress and expansion of researchable 
areas on the study of new therapeutic agents to get novel therapeutic agents for different 
ailments. In order to achieve these aims, studies need integrated supports from 
multidisciplinary stakeholders. 
From the present study, the following works are suggested for further investigation on the 
plant. 
Mechanism of action for antiulcer effects. 
Further quantitative phytochemical investigation to identify and quantify the 
Active anti-ulcer component/s from the plant. 
well-designed NSAID induced ulcer model for analysis of ulcer healing effect by 
treating medications after induction of ulcer 
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9. ANNEXES 
 
 
 
Figure 3- Effect of F.thonningi bark extract on ethanol induced ulcerated mice. 
(A) Negative control  (distilled water+4% tween 80 for 10 days);(B) Treated with standard 
drug  (Misoprostol 5mcg/kg,10days);(C) Treated with CEFT200(10 Days);(D) Treated with 
Aqueous fraction of FT200 and (E)Treated with Chloroform fraction of FT200(10 Days)  
 
 
Figure 4-Efffect of F. thonningii on pylorus ligated Rat mucosa pretreated for 10 days: 
vehicle only (a):CEFT100mg/kg(b),CEFT200 mg/kg(c),CEFT400 mg/kg(d) and Ranitidine 
50 mg/kg(e) 
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